M.Wt: 414.46
Formula: C₂₃H₂₂N₆O₂
Solubility: Unknown
Purity: >99%
Storage: at -20℃ 2 years

CYT387 is an ATP-competitive small molecule JAK1/JAK2 inhibitor with IC50 of 11 and 18 nM for JAK1 and JAK2, respectively.
CYT387 has significantly less activity against other kinases, including JAK3 (IC50=0.16 μM). CYT387 inhibits growth of Ba/F3-JAK2V617F and human erythroleukemia (HEL) cells (IC50 = ~1.5 μM) or Ba/F3-MPLW515L cells (IC50 = 0.2 μM), but CYT387 has considerably less activity against BCR–ABL harboring K562 cells (IC50 = 58 μM). Cell lines harboring mutated JAK2 alleles (CHRF-288-11 or Ba/F3-TEL-JAK2) were inhibited more potently than the corresponding pair harboring mutated JAK3 alleles (CMK or Ba/F3-TEL-JAK3), and STAT-5 phosphorylation was inhibited in HEL cells with an IC50 of 0.4 μM.

To inquire quotation or to ask questions, please send email to sales@chemrenpharm.com to describe your needs. A representative will respond your email shortly. We offer big discount for orders of bulk quantities.